Posted by Michael Wonder on 27 Oct 2025
Flaws in the FDA’s new priority voucher program
25 October 2025 - A new FDA program is being promoted as a tool to facilitate the development and approval of therapies that are important for society.
But it risks undermining regulatory innovation and trust in the agency.
